UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 14, 2021


SC Health Corporation
(Exact name of registrant as specified in its charter)


Cayman Islands
001-38972
N/A
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

108 Robinson Road #10-00
Singapore
 
068900
(Address of principal executive offices)
 
(Zip Code)

+65 6438 1080
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
 
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one half of one warrant
 
SCPE.U
 
New York Stock Exchange LLC
 
Class A ordinary shares, par value $0.0001 per share
 
SCPE
 
New York Stock Exchange LLC
 
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
 
SCPE WS
 
New York Stock Exchange LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07.
Submission of Matters to a Vote of Security Holders.
 
At the Extraordinary General Meeting (the “Extraordinary General Meeting”) of SC Health Corporation, a Cayman Islands exempted company (the “Company”), which was held on April 14, 2021, holders of 16,360,826 of the Company’s ordinary shares, which represents approximately 71.72% of the ordinary shares issued and outstanding and entitled to vote as of the record date of March 18, 2021, were represented in person or by proxy.
 
At the Extraordinary General Meeting, the shareholders approved a special resolution (the “Extension Proposal”) to amend the Company’s amended and restated memorandum and articles of association (the “Articles) to extend the date, from April 16, 2021 to August 16, 2021, by which the Company must either (a) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities or (b) (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem all of the Company’s Class A ordinary shares included as part of the units sold in the Company’s initial public offering that was consummated on July 16, 2019; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining members and the Company’s board of directors, liquidate and dissolve, subject in the case of (ii) and (iii), to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

Approval of Proposal 1—Extension Proposal

Votes For
 
Votes Against
 
Abstentions
 
Broker
Non-Votes
15,772,850
 
587,976
 
0
 
0
 
In connection with the vote to approve the Extension Proposal, the holders of 7,975,485 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.12 per share, for an aggregate redemption amount of approximately $80,711,908 million. As such, approximately 34.96% of the Class A ordinary shares were redeemed and approximately 65.04% of the Class A ordinary shares remain outstanding. After the satisfaction of such redemptions, the balance in the Company’s trust account will be approximately $93,835,584 million.
 
In connection with the vote to approve the Extension Proposal, one holder of seven public warrants properly exercised their right to require the Sponsor to repurchase or cause one of its affiliates to repurchase at $1.00 per public warrant (exclusive of commissions), for an aggregate repurchase amount of $7.00. After the payment for such repurchases, the balance in the escrow account with J.P. Morgan Chase Bank, N.A. will be approximately $8,723,018 million.
 
Under Cayman Islands law, the amendment to the Articles took effect upon approval of the Extension Proposal. Accordingly, the Company now has until August 16, 2021 to consummate its initial business combination. The approval of the Extension Proposal will provide an opportunity for the Company’s shareholders to evaluate the Company’s proposed business combination with Rockley Photonics Limited, a company incorporated under the laws of England and Wales (“Rockley”) pursuant to the Business Combination Agreement and Plan of Merger, by and among the Company, Rockley Photonics Holdings Limited, a Cayman Islands exempted company, Rockley Mergersub Limited, a Cayman Islands exempted company and a direct wholly owned subsidiary of Rockley Photonics Holdings Limited, and Rockley, dated as of March 19, 2021 (the “Business Combination Agreement”), which was disclosed on a Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 19, 2021.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SC Health Corporation
   
Date: April 14, 2021
By:
/s/ Angelo John Coloma
 
Name:
Angelo John Coloma
 
Title:
Chief Executive Officer



SC Health (NYSE:SCPE)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas SC Health.
SC Health (NYSE:SCPE)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas SC Health.